Biogen shares plummeted on Thursday after the company confirmed that it will cease clinical trials for aducanumab, the experimental Alzheimer’s disease treatment it developed alongside its Nikkei 225-listed Japanese partner Eisai.
The chief executive of UBS has called the last three months one of the worst quarters in investment banking’s recent history.
International courier services and air freight giant FedEx reported a sharp drop in both sales and profits for its third quarter, blaming its weaker-than-expected performance on its international arm.
US pharmaceutical group Pfizer has bought a 15% stake in Vivet Therapeutics and now has an exclusive option to buy out the rest of the privately-held French gene therapy company.
Google has been slapped with a €1. 49bn fine by the European Commission for breaking EU antitrust rules by abusing its market dominance in online advertising.
Shares of Bayer were unwanted on Wednesday after a California jury issued a preliminary ruling against the German chemicals maker.
Japan’s Toyota Motor Corporate and Suzuki Motor Corporation have unveiled plans for a wide-ranging collaboration, including jointly producing electric vehicles.
Shares in BMW slid on Wednesday as the German car maker warned that 2019 pre-tax profit would be "well below" the previous year's level amid rising manufacturing costs and announced a new cost-savings plan.
Australian copper producer Aeris Resources has offered to buy Glencore's CSA copper mine in New South Wales for $575m.
The City watchdog has fined UBS more than £27m for failing to keep proper records on nearly 136m transactions over a decade.
Institutional investors are suing Danske Bank for $475m of damages in connection with the money laundering scandal that hit the Danish bank last year.
Jones Lang LaSalle has agreed to buy capital markets services provider HFF in a cash and stock deal worth about $2bn.
Deutsche Bank’s mooted merger with Commerzbank could face opposition from the European Central Bank after the eurozone’s leading financial supervisor said he disliked the idea of national banking champions.
Roche announced on Tuesday that the US Food and Drug Administration (FDA) has approved ‘Tecentriq’ (atezolizumab), in combination with carboplatin and etoposide chemotherapy, for the initial treatment of adults with extensive-stage small cell lung cancer.
Canadian marijuana outfit Tilray posted a wider than expected fourth-quarter loss even though revenues were bigger than forecast.
Ride hailing firm Lyft expects to raise up to $2. 1bn in its upcoming initial public offering, it announced on Monday.
Shares in Nasdaq’s Dermira have more than doubled after the biopharmaceutical company unveiled positive trials for a possible new eczema treatment.
Shares in Deutsche Bank and its smaller rival Commerzbank rallied on Monday, after the two banks confirmed long-held speculation they were in merger talks.
Payments processor Worldpay has agreed to be bought by US financial services technology company FIS in a $43bn deal.